Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure and function of C1-inhibitor.

Ineke G A Wagenaar-Bos1, C Erik Hack

  • 1Department of Immunopathology, Sanquin Research at CLB and Landsteiner Laboratory, Academical Medical Center, University of Amsterdam, Plesmanlaan 125, 1066 CX Amsterdam, the Netherlands. i.bos@sanquin.nl

Immunology and Allergy Clinics of North America
|November 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-function analysis of empasiprubart, a calcium- and pH-dependent clinical phase complement C2 blocking antibody.

mAbs·2026
Same author

Development of an anti-rat complement C2 antibody that improves renal outcome in a rat kidney transplant model.

Frontiers in immunology·2026
Same author

IgM Anti-Ganglioside Binding and Complement Activation in an iPSC-Derived Motor Neuron Model for Multifocal Motor Neuropathy.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same author

Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart.

Nature communications·2025
Same author

Complement activation by IgM autoantibodies linked to immune-mediated neuropathies depends on C2.

European journal of neurology·2024
Same author

IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onset.

Journal of neuroinflammation·2024

Complement component 1 inhibitor (C1-INH) structure, modeled via homology, aids understanding of hereditary angioedema (HAE) mutations. The N-terminal domain

Area of Science:

  • Biochemistry
  • Structural Biology
  • Immunology

Background:

  • C1-INH is a serpin protein crucial for regulating protease activity.
  • Understanding C1-INH structure is key to deciphering its function and associated diseases.
  • Hereditary angioedema (HAE) is linked to C1-INH gene mutations.

Purpose of the Study:

  • To model the three-dimensional structure of the serpin part of C1-INH using homology.
  • To elucidate the biochemical basis of C1-INH mutations found in HAE patients.
  • To explore potential anti-inflammatory roles of the C1-INH N-terminal domain.

Main Methods:

  • Homology modeling was employed to generate a 3D model of the C1-INH serpin domain.
  • Analysis of known C1-INH gene mutations in HAE patients was correlated with the structural model.

Related Experiment Videos

  • Literature review of recent studies on the N-terminal domain's function.

    • Main Results:

    • The homology model provided insights into the functional consequences of C1-INH mutations in HAE.
    • The serpin domain appears critical for C1-INH's inhibitory activity.
    • The N-terminal domain's role in HAE is less clear, but it may have anti-inflammatory functions.

    Conclusions:

    • Structural modeling of C1-INH is valuable for understanding HAE pathogenesis.
    • While the serpin domain is central to C1-INH's protease inhibition, the N-terminal domain may contribute to broader anti-inflammatory effects.
    • Further research into the N-terminal domain could reveal new therapeutic targets for C1-INH-related disorders.